Advertisement

Prediction and Prevention of Sudden Death in the Brugada Syndrome

Published:September 09, 2019DOI:https://doi.org/10.1016/j.amjcard.2019.08.044
      Sudden cardiac death (SCD) secondary to sudden cardiac arrest (SCA) is a leading cause of death in the United States, claiming over a quarter million lives annually, and is directly responsible for 50% of all cardiovascular mortality. Brugada Syndrome (BrS) is an arrhythmogenic cardiovascular channelopathy that predisposes asymptomatic patients who have no identified disease to a high-risk of SCD/SCA as their first cardiac event/disease manifestation. Limited progress has been made in risk prediction of SCA and SCD, with the greatest challenge being the ability to identify the small high-risk subgroups concealed within the larger general population. In conclusion, accurate identification of high-risk asymptomatic BrS patients (through multiparametric risk scores composed of reliable and validated unambiguous clinical variables and biomarkers) may hold utility in improving current SCD prediction algorithms, and the appropriate primary prevention therapy may prove valuable in reducing risk of sudden death for this patient population. This systematic review aims to comprehensively summarize qualitative evidence that explore proposed clinical, electrocardiographic, electrophysiological, and genetic markers for risk stratification of patients with BrS phenotype, and to discuss the best available contemporary evidence regarding therapeutic approach.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Al-Khatib SM
        • Stevenson WG
        • Ackerman MJ
        • Bryant WJ
        • Callans DJ
        • Curtis AB
        • Deal BJ
        • Dickfeld T
        • Field ME
        • Fonarow GC
        • Gillis AM
        • Granger CB
        • Hammill SC
        • Hlatky MA
        • Joglar JA
        • Kay GN
        • Matlock DD
        • Myerburg RJ
        • Page RL
        2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
        Circulation. 2018; 138: e272-e391
        • Watanabe H
        • Minamino T
        Genetics of Brugada syndrome.
        J Hum Genet. 2016; 61: 57-60
        • Priori SG
        • Wilde AA
        • Horie M
        • Cho Y
        • Behr ER
        • Berul C
        • Blom N
        • Brugada J
        • Chiang CE
        • Huikuri H
        • Kannankeril P
        • Krahn A
        • Leenhardt A
        • Moss A
        • Schwartz PJ
        • Shimizu W
        • Tomaselli G
        • Tracy C
        • Document R
        • Ackerman M
        • Belhassen B
        • Estes 3rd, NA
        • Fatkin D
        • Kalman J
        • Kaufman E
        • Kirchhof P
        • Schulze-Bahr E
        • Wolpert C
        • Vohra J
        • Refaat M
        • Etheridge SP
        • Campbell RM
        • Martin ET
        • Quek SC
        • Heart Rhythm S
        • European Heart Rhythm A
        • Asia Pacific Heart Rhythm S
        Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes.
        Europace. 2013; 15: 1389-1406
        • Probst V
        • Veltmann C
        • Eckardt L
        • Meregalli PG
        • Gaita F
        • Tan HL
        • Babuty D
        • Sacher F
        • Giustetto C
        • Schulze-Bahr E
        • Borggrefe M
        • Haissaguerre M
        • Mabo P
        • Le Marec H
        • Wolpert C
        • Wilde AA
        Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada syndrome registry.
        Circulation. 2010; 121: 635-643
        • Priori SG
        • Napolitano C
        • Gasparini M
        • Pappone C
        • Della Bella P
        • Giordano U
        • Bloise R
        • Giustetto C
        • De Nardis R
        • Grillo M
        • Ronchetti E
        • Faggiano G
        • Nastoli J
        Natural history of Brugada syndrome: insights for risk stratification and management.
        Circulation. 2002; 105: 1342-1347
        • Sarkozy A
        • Boussy T
        • Kourgiannides G
        • Chierchia GB
        • Richter S
        • De Potter T
        • Geelen P
        • Wellens F
        • Spreeuwenberg MD
        • Brugada P
        Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome.
        Eur Heart J. 2007; 28: 334-344
        • Antzelevitch C
        • Brugada P
        • Borggrefe M
        • Brugada J
        • Brugada R
        • Corrado D
        • Gussak I
        • LeMarec H
        • Nademanee K
        • Perez Riera AR
        • Shimizu W
        • Schulze-Bahr E
        • Tan H
        • Wilde A
        Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association.
        Circulation. 2005; 111: 659-670
        • Brugada P
        • Brugada J
        Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome.
        J Am Coll Cardiol. 1992; 20: 1391-1396
        • Wilde AA
        • Antzelevitch C
        • Borggrefe M
        • Brugada J
        • Brugada R
        • Brugada P
        • Corrado D
        • Hauer RN
        • Kass RS
        • Nademanee K
        • Priori SG
        • Towbin JA
        Proposed diagnostic criteria for the Brugada syndrome: consensus report.
        Circulation. 2002; 106: 2514-2519
        • Priori SG
        • Blomstrom-Lundqvist C
        • Mazzanti A
        • Blom N
        • Borggrefe M
        • Camm J
        • Elliott PM
        • Fitzsimons D
        • Hatala R
        • Hindricks G
        • Kirchhof P
        • Kjeldsen K
        • Kuck KH
        • Hernandez-Madrid A
        • Nikolaou N
        • Norekval TM
        • Spaulding C
        • Van Veldhuisen DJ
        2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
        Eur Heart J. 2015; 36: 2793-2867
        • Junttila MJ
        • Raatikainen MJ
        • Karjalainen J
        • Kauma H
        • Kesaniemi YA
        • Huikuri HV
        Prevalence and prognosis of subjects with Brugada-type ECG pattern in a young and middle-aged Finnish population.
        Eur Heart J. 2004; 25: 874-878
        • Giustetto C
        • Drago S
        • Demarchi PG
        • Dalmasso P
        • Bianchi F
        • Masi AS
        • Carvalho P
        • Occhetta E
        • Rossetti G
        • Riccardi R
        • Bertona R
        • Gaita F
        Risk stratification of the patients with Brugada type electrocardiogram: a community-based prospective study.
        Europace. 2009; 11: 507-513
        • Benito B
        • Sarkozy A
        • Mont L
        • Henkens S
        • Berruezo A
        • Tamborero D
        • Arzamendi D
        • Berne P
        • Brugada R
        • Brugada P
        • Brugada J
        Gender differences in clinical manifestations of Brugada syndrome.
        J Am Coll Cardiol. 2008; 52: 1567-1573
        • Sacher F
        • Probst V
        • Maury P
        • Babuty D
        • Mansourati J
        • Komatsu Y
        • Marquie C
        • Rosa A
        • Diallo A
        • Cassagneau R
        • Loizeau C
        • Martins R
        • Field ME
        • Derval N
        • Miyazaki S
        • Denis A
        • Nogami A
        • Ritter P
        • Gourraud JB
        • Ploux S
        • Rollin A
        • Zemmoura A
        • Lamaison D
        • Bordachar P
        • Pierre B
        • Jais P
        • Pasquie JL
        • Hocini M
        • Legal F
        • Defaye P
        • Boveda S
        • Iesaka Y
        • Mabo P
        • Haissaguerre M
        Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
        Circulation. 2013; 128: 1739-1747
        • Priori SG
        • Gasparini M
        • Napolitano C
        • Della Bella P
        • Ottonelli AG
        • Sassone B
        • Giordano U
        • Pappone C
        • Mascioli G
        • Rossetti G
        • De Nardis R
        • Colombo M
        Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.
        J Am Coll Cardiol. 2012; 59: 37-45
        • Takagi M
        • Aonuma K
        • Sekiguchi Y
        • Yokoyama Y
        • Aihara N
        • Hiraoka M
        The prognostic value of early repolarization (J wave) and ST-segment morphology after J wave in Brugada syndrome: multicenter study in Japan.
        Heart Rhythm. 2013; 10: 533-539
        • Takagi M
        • Sekiguchi Y
        • Yokoyama Y
        • Aihara N
        • Hiraoka M
        • Aonuma K
        The prognostic impact of single extra-stimulus on programmed ventricular stimulation in Brugada patients without previous cardiac arrest: multi-centre study in Japan.
        Europace. 2018; 20: 1194-1200
        • Delise P
        • Allocca G
        • Marras E
        • Giustetto C
        • Gaita F
        • Sciarra L
        • Calo L
        • Proclemer A
        • Marziali M
        • Rebellato L
        • Berton G
        • Coro L
        • Sitta N
        Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach.
        Eur Heart J. 2011; 32: 169-176
        • Gonzalez Corcia MC
        • Sieira J
        • Pappaert G
        • de Asmundis C
        • Chierchia GB
        • Sarkozy A
        • Brugada P
        A clinical score model to predict lethal events in young patients (</=19 Years) with the Brugada syndrome.
        Am J Cardiol. 2017; 120: 797-802
        • Kamakura S
        • Ohe T
        • Nakazawa K
        • Aizawa Y
        • Shimizu A
        • Horie M
        • Ogawa S
        • Okumura K
        • Tsuchihashi K
        • Sugi K
        • Makita N
        • Hagiwara N
        • Inoue H
        • Atarashi H
        • Aihara N
        • Shimizu W
        • Kurita T
        • Suyama K
        • Noda T
        • Satomi K
        • Okamura H
        • Tomoike H
        Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3.
        Circ Arrhythm Electrophysiol. 2009; 2: 495-503
        • Casado-Arroyo R
        • Berne P
        • Rao JY
        • Rodriguez-Manero M
        • Levinstein M
        • Conte G
        • Sieira J
        • Namdar M
        • Ricciardi D
        • Chierchia GB
        • de Asmundis C
        • Pappaert G
        • La Meir M
        • Wellens F
        • Brugada J
        • Brugada P
        Long-term trends in newly diagnosed Brugada syndrome: implications for risk stratification.
        J Am Coll Cardiol. 2016; 68: 614-623
        • Calo L
        • Giustetto C
        • Martino A
        • Sciarra L
        • Cerrato N
        • Marziali M
        • Rauzino J
        • Carlino G
        • de Ruvo E
        • Guerra F
        • Rebecchi M
        • Lanzillo C
        • Anselmino M
        • Castro A
        • Turreni F
        • Penco M
        • Volpe M
        • Capucci A
        • Gaita F
        A new electrocardiographic marker of sudden death in Brugada syndrome: the S-wave in lead I.
        J Am Coll Cardiol. 2016; 67: 1427-1440
        • Gray B
        • Kirby A
        • Kabunga P
        • Freedman SB
        • Yeates L
        • Kanthan A
        • Medi C
        • Keech A
        • Semsarian C
        • Sy RW
        Twelve-lead ambulatory electrocardiographic monitoring in Brugada syndrome: potential diagnostic and prognostic implications.
        Heart Rhythm. 2017; 14: 866-874
        • Andorin A
        • Gourraud JB
        • Mansourati J
        • Fouchard S
        • le Marec H
        • Maury P
        • Mabo P
        • Hermida JS
        • Deharo JC
        • Delasalle B
        • Esnault S
        • Sadoul N
        • Davy JM
        • Leenhardt A
        • Klug D
        • Defaye P
        • Babuty D
        • Sacher F
        • Probst V
        The QUIDAM study: hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.
        Heart Rhythm. 2017; 14: 1147-1154
        • Viskin S
        • Wilde AA
        • Guevara-Valdivia ME
        • Daoulah A
        • Krahn AD
        • Zipes DP
        • Halkin A
        • Shivkumar K
        • Boyle NG
        • Adler A
        • Belhassen B
        • Schapachnik E
        • Asrar F
        • Rosso R
        Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries.
        J Am Coll Cardiol. 2013; 61: 2383-2387
        • Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
        A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
        N Engl J Med. 1997; 337: 1576-1583
        • Connolly SJ
        • Hallstrom AP
        • Cappato R
        • Schron EB
        • Kuck KH
        • Zipes DP
        • Greene HL
        • Boczor S
        • Domanski M
        • Follmann D
        • Gent M
        • Roberts RS
        Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac arrest study Hamburg. Canadian implantable defibrillator study.
        Eur Heart J. 2000; 21: 2071-2078
        • Olde Nordkamp LR
        • Postema PG
        • Knops RE
        • van Dijk N
        • Limpens J
        • Wilde AA
        • de Groot JR
        Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications.
        Heart Rhythm. 2016; 13: 443-454
        • Hernandez-Ojeda J
        • Arbelo E
        • Borras R
        • Berne P
        • Tolosana JM
        • Gomez-Juanatey A
        • Berruezo A
        • Campuzano O
        • Sarquella-Brugada G
        • Mont L
        • Brugada R
        • Brugada J
        Patients with Brugada syndrome and implanted cardioverter-defibrillators: long-term follow-up.
        J Am Coll Cardiol. 2017; 70: 1991-2002